Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review.

Authors : Draguet F, Bouland C, Dubois N, Bron D, Meuleman N, Stamatopoulos B, Lagneaux L
Year : 2023
Journal : Pharmaceutics
Volume : 15

Recommendations on the management of multiple myeloma in 2020.

Authors : Vekemans MC, Doyen C, Caers J, Wu K, Kentos A, Mineur P, Michaux L, Delforge M, Meuleman N
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 445-461

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.

Authors : Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S
Year : 2022
Journal : Hemasphere
Volume : 6
Pages : e813

Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases.

Authors : Bouhtit F, Najar M, Rahmani S, Melki R, Najimi M, Sadki K, Boukhatem N, Twizere JC, Meuleman N, Lewalle P, Lagneaux L, Merimi M
Year : 2022
Journal : Inflamm Res
Volume : 71
Pages : 887-898

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.

Authors : Bobin A, Kyheng M, Guidez S, Gruchet-Merouze C, Richez V, Duhamel A, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Perrot A, Roussel M, Jaccard A, Petillon MO, Belhadj-Merzoug K, Chretien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Moreau P, Avet-Loiseau H, Hulin C, Facon T, Leleu X
Year : 2022
Journal : Leukemia
Volume : 36
Pages : 881-884

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Authors : Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M
Year : 2022
Journal : Cancers (Basel)
Volume : 14

Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF.

Authors : Bouland C, Meuleman N, Widelec J, Keiani-Mothlagh K, Voisin C, Lagneaux L, Philippart P
Year : 2021
Journal : J Stomatol Oral Maxillofac Surg
Volume : 122
Pages : 212-218

Rational Approach Of Older Patients With Chronic Lymphocytic Leukaemia.

Authors : Massaro F, Vandevoorde C, Ku J, Papazoglou D, Van Uytvanck A, Meuleman N, Bron D
Year : 2021
Journal : Belgian J Hematology
Volume : 12(4)
Pages : 147-54

Highlights In Multiple Myeloma.

Authors : Meuleman N, Vercruyssen M
Year : 2021
Journal : Belgian J Hematology
Volume : 12(5)
Pages : 220-2

Guidelines Of The Belgian Hematology Society For Imaging In Multiple Myeloma.

Authors : Meuleman N, Caers J, Fostier K, Vlummens P, Pans S, Goethals I, Alexiou J, Cliquennois M, Doyen C, De Weweire A, Schots R, Delforge M, Vekemans MC
Year : 2021
Journal : Belgian J Hematology
Volume : 12(8)
Pages : 338-343

Primary gastric plasmatytoma: case report of a rare plasma cell neoplasm.

Authors : Rizzo O, Bron D, Vercruyssen M, de Wind A, Roelandts M, Eisendrath P, Lemmers A, Meuleman N
Year : 2021
Journal : Belgian J Hematology
Volume : 12(8)
Pages : 349–52

Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.

Authors : Bouland C, Philippart P, Dequanter D, Corrillon F, Loeb I, Bron D, Lagneaux L, Meuleman N
Year : 2021
Journal : Front Cell Dev Biol
Volume : 9
Pages : 674084

Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic.

Authors : Merimi M, Lewalle P, Meuleman N, Agha DM, El-Kehdy H, Bouhtit F, Ayoub S, Burny A, Fahmi H, Lagneaux L, Najar M
Year : 2021
Journal : J Clin Med
Volume : 10

Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules.

Authors : Merimi M, Lagneaux L, Lombard CA, Agha DM, Bron D, Lewalle P, Meuleman N, Najimi M, Sokal EM, Najar M
Year : 2021
Journal : Inflamm Res
Volume : 70
Pages : 229-239

Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.

Authors : Debaugnies F, Mahadeb B, Nagant C, Meuleman N, De Bels D, Wolff F, Gottignies P, Salaroli A, Borde P, Voué M, Corazza F
Year : 2021
Journal : J Clin Immunol
Volume : 41
Pages : 658-665

New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways.

Authors : Bouhtit F, Najar M, Moussa Agha D, Melki R, Najimi M, Sadki K, Boukhatem N, Bron D, Meuleman N, Hamal A, Lagneaux L, Lewalle P, Merimi M
Year : 2021
Journal : Molecules
Volume : 26

SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.

Authors : Van Uytvanck A, Wittnebel S, Meuleman N, Loizidou A, Salengros JC, Spilleboudt C
Year : 2021
Journal : Clin Case Rep
Volume : 9
Pages : e04439

Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.

Authors : Dimov I, Meuleman N, de Cannière D, Unger P
Year : 2021
Journal : Eur Heart J Case Rep
Volume : 5
Pages : ytab322

The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.

Authors : Merimi M, El-Majzoub R, Lagneaux L, Moussa Agha D, Bouhtit F, Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M
Year : 2021
Journal : Front Cell Dev Biol
Volume : 9
Pages : 661532

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study.

Authors : Tremblay G, Daniele P, Breeze J, Li L, Shah J, Shacham S, Kauffman M, Engelhardt M, Chari A, Nooka A, Vogl D, Gavriatopoulou M, Dimopoulos MA, Richardson P, Biran N, Siegel D, Vlummens P, Doyen C, Facon T, Mohty M, Meuleman N, Levy M, Costa L, Hoffman JE, Delforge M, Kaminetzky D, Weisel K, Raab M, Dingli D, Tuchman S, Laurent F, Vij R, Schiller G, Moreau P, Richter J, Schreder M, Podar K, Parker T, Cornell RF, Lionel K, Choquet S, Sundar J
Year : 2021
Journal : BMC Cancer
Volume : 21
Pages : 993